Flemming Winther Bach

Udredning og behandling af autoimmun encefalitis

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

  • Morten Blaabjerg, Neurologisk Afdeling, Odense Universitetshospital
  • ,
  • Camilla C Mærsk-Møller, Institut for Klinisk Medicin - Neurologisk Afdeling F, NBG, Danmark
  • Daniel Kondziella, Neurologisk klinik, Rigshospitalet, Danmark
  • Finn Somnier, Afdelingen for Autoimmunologi og Markører, Statens Seruminstitut, Danmark
  • Marko Celicanin, Neurologisk Afdeling, Nordsjællands Hospital, Danmark
  • Henning Andersen
  • Flemming Winther Bach
  • Lars H Pinborg, Neurobiologisk Forskningsenhed, Rigshospitalet

Autoimmune encephalitis with antibodies against neuronal surface antigens is diagnosed with increasing frequency in recent years. If treated early and aggressively, these conditions often respond favourably to immunotherapy. We describe the clinical features, diagnosis and treatment of the two most common types of autoimmune encephalitis with antibodies against the N-methyl-D-aspartate receptor or the leucine-rich glioma-inactivated 1 protein. Together, these two conditions comprise 80% of the autoimmune encephalitis cases diagnosed in Denmark. Autoimmune encephalitides with rare antibodies are also summarized.

OriginalsprogDansk
ArtikelnummerV05150448
TidsskriftUgeskrift for Laeger
Vol/bind177
Nummer45
Sider (fra-til)2-7
ISSN0041-5782
StatusUdgivet - 2 nov. 2015

Se relationer på Aarhus Universitet Citationsformater

ID: 95781643